Furthermore, we found four RPL/RPS members of the melanoma CTC signature (RPL23, RPL35A, RPL6, and RPS18) of 21 RPL/RPS genes to be keenly involved in metastatic progression. The gene discussed is RPL23; the disease is melanoma.